Abstract: The present application is directed to stable preservative free ophthalmic formulations of opioid antagonists and use thereof in the treatment of retinal degenerative diseases.
Type:
Application
Filed:
July 16, 2015
Publication date:
August 10, 2017
Applicant:
IMUNEKS FARMA ILAC SANAYI VE TICARET ANONIM SIRKET